Electromed (ELMD) EPS (Basic) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Electromed | 300.53 Mn | 283.55 Mn | 14.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.28% |
| Dec 31, 2025 | 18.71% |
| Sep 30, 2025 | 34.08% |
| Jun 30, 2025 | 10.20% |
| Mar 31, 2025 | 22.42% |
| Dec 31, 2024 | 10.44% |
| Sep 30, 2024 | 7.21% |
| Jun 30, 2024 | 10.07% |
| Mar 31, 2024 | 33.56% |
| Dec 31, 2023 | 31.95% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 1.76% |
| Mar 31, 2023 | 21.06% |
| Dec 31, 2022 | 19.14% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | -18.32% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 14.87% |
| Sep 30, 2021 | 20.11% |
| Jun 30, 2021 | 4.56% |
| Mar 31, 2021 | -12.94% |
| Dec 31, 2020 | 1.49% |
| Sep 30, 2020 | 8.45% |
| Jun 30, 2020 | 39.77% |
| Mar 31, 2020 | 77.13% |
| Dec 31, 2019 | 22.87% |
| Sep 30, 2019 | 19.14% |
| Jun 30, 2019 | 34.08% |
| Mar 31, 2019 | 18.47% |
| Dec 31, 2018 | 29.67% |
| Sep 30, 2018 | 20.11% |
| Jun 30, 2018 | 33.24% |
| Mar 31, 2018 | 24.57% |
| Dec 31, 2017 | 24.57% |
| Sep 30, 2017 | 24.57% |
| Jun 30, 2017 | 41.47% |
| Mar 31, 2017 | 51.57% |
| Dec 31, 2016 | 75.18% |
| Sep 30, 2016 | -7.79% |
| Jun 30, 2016 | 14.87% |
| Mar 31, 2016 | 0.00% |
| Dec 31, 2015 | 26.58% |
| Sep 30, 2015 | 14.87% |